An Open-label, Randomized, Parallel-Group, Multi-Site Study to Evaluate the Efficacy and Safety of Azelastine HCl-Fluticasone Propionate Nasal Spray 137-50 mcg/Spray in Perennial Allergic Rhinitis Patients
Latest Information Update: 03 Oct 2023
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Synmosa Biopharma
Most Recent Events
- 03 Oct 2023 New trial record